StonvexLoading…
StonvexStonvexStonvexCore line items from EVMN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 |
|---|---|---|
Revenue | $13.00M | $7.00M |
Operating Income | $-81.07M | $-70.01M |
Net Income | $-68.87M | $-66.81M |
EPS (Diluted) | $-11.22 | $-45.29 |
Total Assets | $224.95M | $76.06M |
Total Liabilities | $19.38M | $28.52M |
Cash & Equivalents | $44.06M | $16.25M |
Free Cash Flow OCF − CapEx | $-76.68M | $-58.28M |
Shares Outstanding | 31.52M | 1.55M |